Ortivus AB ser. B

Ortivus AB ser. B

ORTI-B · ST · Healthcare / Medical Instruments & Supplies

1.15SEK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close1.15
Open1.15
Day Range1.15 – 1.15
52-Week Range0.802 – 2.14
Volume790
Market Cap134.69M
P/E (TTM)0.00
Forward P/E8.06
EPS-0.29
Dividend Yield0.00%
Beta0.90
50-Day Avg1.82
200-Day Avg1.67

About

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides emergency medical services, primary care, and rescue services. The company was founded in 1985 and is headquartered in Danderyd, Sweden. Ortivus AB (publ) is a subsidiary of Ponderus Invest AB.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Gustaf Nordenhok
  • Employees32
  • HeadquartersSvaerdvaegen 19, Danderyd, Sweden, 182 33, Sweden
  • Websitehttps://www.ortivus.com

Leadership

  • Mr. Gustaf NordenhokChief Executive Officer
  • Ms. Minni RaijChief Financial Officer
  • Mr. Gabriel ÅhbeckChief Technology Officer · b. 1971
  • Ms. Emma MattssonChief Marketing Officer
  • Mr. Elias ObaidChief Commercial Officer · b. 1988
  • Jesper EklundHead of Swedish Service & Support Team
  • Ms. Jessica NylanderHead of Customer Success
  • Mr. Nicklas TryggHead of Business Development
  • Mr. Matti ZemackChief Product Officer · b. 1973

Financials

Income Statement

Currency: SEK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue175.21M140.81M173.55M199.78M162.41M83.11M105.04M47.73M45.75M60.71M36.10M69.37M72.62M74.28M58.80M52.20M50.85M107.58M94.27M104.51M84.08M80.41M73.40M
Growth (%)--19.63%+23.25%+15.11%-18.70%-48.82%+26.38%-54.56%-4.14%+32.71%-40.53%+92.12%+4.69%+2.29%-20.84%-11.22%-2.59%+111.58%-12.37%+10.86%-19.55%-4.36%-8.72%
Cost of Revenue38.74M18.03M57.95M78.02M55.69M22.54M26.80M22.18M24.52M26.85M16.48M22.46M15.97M25.69M28.82M30.15M29.86M68.63M46.40M55.78M53.24M52.48M43.80M
Gross Profit136.46M122.78M115.60M121.75M106.72M60.57M78.24M25.55M21.23M33.86M19.63M46.90M56.65M48.59M29.97M22.05M20.99M38.95M47.87M48.72M30.84M27.93M29.60M
Gross Margin77.89%87.19%66.61%60.94%65.71%72.88%74.49%53.54%46.40%55.78%54.36%67.62%78.00%65.41%50.98%42.24%41.27%36.21%50.78%46.62%36.68%34.74%40.33%
Operating Expense121.87M107.72M137.43M250.14M160.63M102.43M95.86M58.15M59.41M31.87M33.72M45.23M62.18M53.70M40.42M34.99M36.04M27.56M38.52M42.88M48.45M47.47M44.05M
Operating Income14.59M15.05M-21.84M-128.39M-53.91M-41.86M-17.62M-32.59M-38.18M1.99M-14.10M1.67M-5.54M-5.11M-10.45M-12.94M-15.06M11.39M9.35M5.85M-17.61M-19.53M-14.45M
Operating Margin8.33%10.69%-12.58%-64.27%-33.19%-50.36%-16.77%-68.29%-83.45%3.28%-39.04%2.40%-7.62%-6.88%-17.77%-24.80%-29.61%10.59%9.91%5.59%-20.95%-24.29%-19.68%
EBITDA14.59M24.53M-16.41M-125.24M-30.93M8.88M-17.62M-23.44M-22.77M5.21M-10.82M7.46M9.69M13.59M-387.00K-4.97M-8.54M13.05M11.28M8.61M-14.93M-16.86M-10.59M
EBITDA Margin8.33%17.42%-9.46%-62.69%-19.05%10.69%-16.77%-49.11%-49.78%8.59%-29.96%10.76%13.35%18.29%-0.66%-9.53%-16.80%12.13%11.97%8.23%-17.75%-20.96%-14.42%
Net Income7.67M12.99M-17.71M-149.19M-61.29M-68.95M-18.48M-22.27M-37.86M2.22M-14.04M1.40M-7.09M-7.08M-11.61M-13.39M-16.01M11.33M9.21M5.89M-18.25M-24.90M-21.88M
Net Income Margin4.38%9.23%-10.21%-74.68%-37.74%-82.95%-17.59%-46.66%-82.76%3.66%-38.89%2.02%-9.76%-9.53%-19.74%-25.65%-31.48%10.53%9.77%5.64%-21.70%-30.97%-29.80%
R&D40.68M29.24M39.46M67.22M61.61M41.57M41.27M25.04M24.79M7.93M6.15M4.12M7.54M13.12M13.04M10.76M8.78M4.69M3.29M3.29M9.54M10.80M7.71M
R&D as % of Total Revenue23.22%20.77%22.74%33.65%37.94%50.02%39.29%52.47%54.19%13.07%17.03%5.93%10.39%17.66%22.18%20.61%17.28%4.36%3.49%3.15%11.35%13.44%10.50%
Interest Expense0394.00K1.76M2.54M1.40M536.00K2.03M266.00K181.00K2.00K10.00K289.00K1.56M1.97M1.16M449.00K538.00K97.00K166.00K11.00K578.00K3.60M1.86M
Interest Expense % of Total Revenue0.00%0.28%1.02%1.27%0.86%0.64%1.93%0.56%0.40%0.00%0.03%0.42%2.15%2.65%1.97%0.86%1.06%0.09%0.18%0.01%0.69%4.47%2.53%

Balance Sheet

Currency: SEK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets262.38M258.87M356.27M333.90M253.45M181.28M164.13M83.51M51.03M53.19M36.78M82.80M66.05M47.25M34.54M27.70M34.94M66.55M72.46M89.75M72.71M63.91M70.93M
Total Liabilities37.29M34.40M126.55M107.87M90.42M74.76M79.50M16.56M22.00M22.00M19.57M63.46M53.68M42.02M18.98M25.52M26.19M46.87M43.02M54.31M55.40M71.07M48.52M
Total Equity225.09M224.47M229.72M226.03M163.02M106.52M84.63M66.95M29.03M31.19M17.21M19.35M12.36M5.22M15.55M2.18M8.75M19.68M29.44M35.44M17.30M-7.17M22.41M
Cash94.48M68.17M20.58M90.78M57.18M50.51M35.30M28.14M13.68M20.44M7.89M11.73M1.22M2.04M1.70M3.36M8.68M22.13M22.11M7.60M1.29M7.28M8.89M
Total Debt--38.64M35.19M21.52M28.80M28.75M----6.10M24.08M20.07M10.04M13.02M3.18M1.01M3.31M6.22M5.48M38.03M19.53M
Net Debt-94.48M-68.17M18.07M-55.59M-35.66M-21.70M-6.55M-28.14M-13.68M-20.44M-7.89M-5.63M22.86M18.03M8.34M9.66M-5.50M-21.12M-18.80M-1.38M4.19M32.88M10.64M

Cash Flow

Currency: SEK2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow60.91M55.57M-18.16M-40.42M-1.40M-18.98M-10.05M-26.69M-8.69M8.95M-7.13M31.93M-3.39M4.93M-11.90M-510.00K-3.51M18.63M7.77M-6.88M-303.00K-9.75M-25.24M
Investing Cash Flow32.77M76.90M-61.69M-40.28M-23.00M-370.00K-3.22M49.54M-5.60M-1.97M-5.43M-27.59M-10.62M302.00K-350.00K-818.00K-609.00K-2.73M-6.70M-6.15M-14.76M-7.59M-9.63M
Financing Cash Flow-71.26M2.77M28.92M152.85M-8.55M8.22M--28.34M-71.00K-358.00K358.00K3.28M-4.34M11.91M2.98M9.44M-2.17M-1.24M-1.49M8.73M23.33M36.48M
Capital Expenditure2.14M30.15M32.74M40.27M23.68M12.69M3.49M5.53M5.66M1.97M5.43M27.59M10.62M44.00K350.00K818.00K609.00K2.73M6.70M6.09M10.76M35.00K25.24M
Free Cash Flow58.77M25.42M-50.90M-80.69M-25.08M-31.66M-13.54M-32.23M-14.34M6.98M-12.56M4.35M-14.01M4.89M-12.25M-1.33M-4.12M15.90M1.07M-12.97M-11.06M-9.75M-34.83M
FCF to OCF96.48%45.74%280.27%199.64%1796.28%166.86%134.68%120.72%165.10%78.02%176.15%13.62%413.67%99.11%102.94%260.39%117.35%85.33%13.79%188.59%3651.82%100.00%138.02%

Earnings

Report DateFeb 22, 2006May 19, 2006Aug 25, 2006Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Oct 14, 2011Feb 22, 2012Apr 20, 2012Jul 12, 2012Oct 18, 2012Dec 31, 2012Mar 31, 2013Jul 12, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate0.10-0.31-0.28------------------------------------------------------------------------
EPS Actual-0.12-0.22-0.62-0.15-0.92-0.22-0.17-0.21-0.14-0.01-0.44-0.28-0.18-0.20-0.48-0.36-0.49-0.120.140.15-0.08-0.07-0.12-0.10-0.280.080.060.07-0.150.01-0.00-0.21-0.08-0.20-0.130.000.04-0.10-0.14-0.12-0.07-0.12-0.15-0.03-0.13-0.16-0.13-0.08-0.040.020.150.030.050.040.070.060.040.040.080.010.000.01-0.11-0.25-0.06-0.05-0.19-0.10-0.22-0.06-0.15-0.13-0.10-0.00-0.04
Surprise-220.00%29.03%-121.43%------------------------------------------------------------------------
TimingPre-marketPre-marketPre-market------------Pre-marketPre-marketAfter-hoursPre-marketPre-market--Pre-market----------------------------------------------------

Key Statistics & Ratios

Market Cap134.69M
Enterprise Value166.21M
Trailing P/E0.00
Forward P/E8.06
PEG Ratio0.50
Price / Sales1.76
Price / Book7.95
EPS-0.29
Book Value0.201
Revenue (TTM)76.40M
Gross Profit (TTM)29.24M
EBITDA-18.24M
Profit Margin-23.41%
Operating Margin-31.77%
Return on Equity-2201.35%
Return on Assets-17.33%
Shares Outstanding86.95M
Shares Float9.15M
Beta0.90
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 20, 2019429:427
  • May 19, 2017117:98
  • Jun 9, 200659:56
  • Apr 23, 19982:1